Porta-Etessam, J., González-García, N., Guerrero, Á., & García-Azorín, D. (2021). Failure of monoclonal antibodies against CGRP or its receptor does not imply lack of efficacy of other drugs from the same class. Neurología (Barcelona, English ed. ), 36(8), 638-640. https://doi.org/10.1016/j.nrleng.2020.10.008
Chicago-Zitierstil (17. Ausg.)Porta-Etessam, J., N. González-García, Á.L Guerrero, und D. García-Azorín. "Failure of Monoclonal Antibodies Against CGRP or Its Receptor Does Not Imply Lack of Efficacy of Other Drugs from the Same Class." Neurología (Barcelona, English Ed. ) 36, no. 8 (2021): 638-640. https://doi.org/10.1016/j.nrleng.2020.10.008.
MLA-Zitierstil (9. Ausg.)Porta-Etessam, J., et al. "Failure of Monoclonal Antibodies Against CGRP or Its Receptor Does Not Imply Lack of Efficacy of Other Drugs from the Same Class." Neurología (Barcelona, English Ed. ), vol. 36, no. 8, 2021, pp. 638-640, https://doi.org/10.1016/j.nrleng.2020.10.008.